Whitaker Brett, Alroy Karen A, Guthrie Erica, Schildecker Sarah, Hiers Susan, Woodard Jill, Balajee S Arunmozhi
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
Afr J Lab Med. 2019 Jul 18;8(1):861. doi: 10.4102/ajlm.v8i1.861. eCollection 2019.
Endemic and emerging respiratory viruses are a threat to public health, and a robust public health laboratory system is essential to ensure global health security.
This program sought to expand molecular laboratory testing capacity to detect a broad range of respiratory pathogens in clinical respiratory specimens collected during disease surveillance and outbreak investigations.
As a part of the Global Health Security Agenda (GHSA), the United States Centers for Disease Control and Prevention utilised the equipment and training infrastructure already in place at the World Health Organization National Influenza Centers to expand testing capacity for respiratory viruses in laboratories in GHSA partner countries. This was done through the provision of quality assured reagents, including multiplex platforms and technical guidance for laboratory staff, as well as the assessment of laboratory testing accuracy.
Early findings illustrated that GHSA laboratories have been able to expand testing capacity using specimens from routine surveillance, as well as from outbreak situations.
地方性和新出现的呼吸道病毒对公众健康构成威胁，强大的公共卫生实验室系统对于确保全球卫生安全至关重要。
该项目旨在扩大分子实验室检测能力，以检测在疾病监测和疫情调查期间收集的临床呼吸道标本中的多种呼吸道病原体。
作为全球卫生安全议程（GHSA）的一部分，美国疾病控制与预防中心利用世界卫生组织国家流感中心现有的设备和培训基础设施，扩大GHSA伙伴国家实验室对呼吸道病毒的检测能力。这是通过提供质量有保证的试剂（包括多重检测平台）、为实验室工作人员提供技术指导以及评估实验室检测准确性来实现的。
早期结果表明，GHSA实验室已能够利用常规监测标本以及疫情情况下的标本扩大检测能力。
